Drug Bioavailability Optimisation – DRUGBIOP

CV Prof. Ana Melero Zaera

Ana Melero is an Associate Professor at the University of Valencia. She obtained her PhD in Pharmacy in 2009 with a dissertation on a nortriptyline hydrochloride transdermal patch for smoking cessation, supervised by Dr. Teresa María Garrigues and Prof. Claus-Michael Lehr within the European Galenos Network doctoral programme. After three years of postdoctoral research at the Helmholtz Institute for Pharmaceutical Sciences, Germany, she joined the University of Valencia in Pharmaceutical Technology. Her research focuses on advanced drug delivery systems, particularly micro- and nanotechnology-based approaches to enhance drug absorption and targeted delivery. She leads the DrugBiOp research group, supported by public and private projects, with fifteen publications in the last five years. Since 2018, she has actively contributed to the Controlled Release Society, chairing its Young Scientist Committee in 2023. Her achievements include three CRS awards and mentoring the winning team of the 2022 Alfathon hackathon with the innovative SituGel project.


Design of materials for drug targeting and cosmetic use. 

In vivo models of skin inflamation (dermatitis and psoriasis) and colonic inflamation (IBD). 

Drug absorption through intestinal mucosae, lung epitelia, eye and skin.

Excipient influence. Biopharmaceutical assessment.

Nanopartículas biomiméticas y vesículas extracelulares para tratamiento tópico de enfermedades inflamatorias de la piel y cicatrización de heridas: retos y soluciones. (BIONPS&EVS@SKIN). PID2023-149611NB-I00Agencia Estatal de Investigación (AEI). 2024-2027. Ana Melero Zaera 

Extensión del protocolo estándar para la realización de estudios por sonoforesis -solución de retos y desarrollo clínico hacia mercado. CPP2024-011430Agencia Estatal de Investigación (AEI). 2025-2028. Ana Melero Zaera

Guillot, A.J; Martínez-Navarrete, M.; Giner, R.M. et al. Cyanocobalamin-loaded dissolving microneedles diminish skin inflammation in vivo. Journal of Controlled Release2024. 375, 537-551. https://doi.org/10.1016/j.jconrel.2024.09.032  

Martínez-Navarrete, M.; Guillot, A.J.; Lobita, M.C. et al. Cyclosporin A-loaded dissolving microneedles for dermatitis therapy: Development, characterisation and efficacy in a delayed-type hypersensitivity in vivo model. Drug Delivery and Translational Research2024. 14, 3404-3421. https://doi.org/10.1007/s13346-024-01542-9 

Martínez-Navarrete, M.; Guillot, A.J; Giner, R.M. et al. Ultraflexible lipid vesicles loaded with cyanocobalamin or cyclosporin A downregulate acute and chronic immuno-inflammatory skin states. Journal of Controlled Release. 2026. 389, 114461. https://doi.org/10.1016/j.jconrel.2025.114461

Tashiro, F.M.; Lobato Duarte, J.; Martínez Navarrete, M. et al. Preparation, Characterization, and Keratinocyte Cell Viability of a β-Cyclodextrin–Myrcene Complex Intended for Skin Application. ACS Omega2026. 11, 25, 37454-37466. https://doi.org/10.1021/acsomega.6c01078 


Prof. Rosa María Giner Pons


Prof. Mª Carmen Recio Iglesias


Miquel Martínez Navarrete